The world's first malaria vaccine got a green light on Friday from European drugs regulators who recommended it should be licensed for use in babies in Africa at risk of the mosquito-borne disease.
The shot, called RTS,S or Mo
The World Bank Group has approved a $121 million credit and grant to support the Sahel Malaria and Neglected Tropical Diseases Project in Africa, according to a report.
It aims to increase access to community-level health services
World Health Organisation (WHO) member states have agreed to a new global malaria strategy for 2016-30 and approved the organization’s proposed programme budget for 2016-17.
The strategy aims to reduce the global disea
The world's first malaria vaccine, made by GlaxoSmithKline, could be approved by international regulators for use in Africa from October after final trial data showed it offered partial protection for up to four years.
Malaria deaths have dropped dramatically since 2000 and cases are falling steadily thanks to more people being diagnosed and treated and more getting bed nets, the World Health Organization (WHO) said on Tuesday.
Yet progress agai
Global efforts to eliminate malaria have saved an estimated 3.3 million lives since 2000, reducing malaria mortality rates by 45 per cent globally, according to the World malaria report 2013 published by the World Health Organization (WHO).
British drugmaker GlaxoSmithKline will seek marketing approval for the world's first malaria vaccine next year after trial data showed the shot significantly cut cases of the disease in African children.
An experimental malaria vaccine proved highly effective in a small, early-stage clinical trial in people, raising hope in the global effort to combat the deadly disease, US researchers reported on Thursday in the journal Science.
Global funding for the fight against malaria has stalled in the past two years, threatening to reverse what the World Health Organisation (WHO) says are "remarkable recent gains" in the battle to control one of the world's leading
A GlaxoSmithKline experimental malaria vaccine touted as a new weapon in the fight to eradicate the disease proved only 30 percent effective when given to babies as part Africa's largest ever clinical trial.